FUSF Newsletter: Volume 19
|
 |
|
|
 |
|
|
 |
|
|
 |
Dear Subscriber,
Abstract submissions and registration open this month for our upcoming 2nd International Symposium on MR-guided Focused Ultrasound. The lead story in this issue provides up to the minute information about both.
In the months and weeks leading up to the symposium, subscribing to this newsletter will give you access to updates about speakers, topics and other important details. Subscribers will receive special email messages and monthly previews of the presenters and research, the scientific and poster sessions, and the sponsors and exhibits that will make this year’s symposium the premier event for modern medicine’s most exciting forefront.
We encourage you to forward this newsletter to colleagues and collaborators who have an interest in MR-guided focused ultrasound. Suggest that they become subscribers, too. Don’t let them miss out on news about the symposium and the emerging and quickly evolving field of MR-guided focused ultrasound.
If you are not yet a newsletter subscriber, please click here to be added to our distribution list.
|
 |
 |
|
Monteith will investigate MR-guided FUS as treatment for intracerebral hemorrhage
|
Deadly brain hemorrhages are the subject of focused ultrasound research being performed by Stephen Monteith, M.D., a senior neurosurgery resident at the University of Virginia.
One of nine grant recipients recently announced by the Neurosurgery Research and Education Foundation (NREF) of the American Association of Neurological Surgeons (AANS), Monteith received the prestigious research fellowship in the Cerebrovascular Section. He will investigate the in vivo use of MR-guided FUS to treat intracerebral hematomas, which are clots that form within the brain tissue due to ruptured blood vessels caused by a stroke or traumatic injury.
|
Shown in photo: NREF fellowship recipient Stephen Monteith and FUS Foundation Brain team members Eben Alexander and John Snell
|
Back to Top
|
|
 |
 |
 |
 |
|
The Caruthers Foundation of Arlington, Virginia has donated $100,000 to the FUS Foundation.
In a note, Preston Caruthers wrote, “We are pleased to help the Focused Ultrasound Surgery Foundation on its quest to deliver medically advanced methods of treating breast tumors, brain tumors, uterine fibroids, blood clots and bone metastases. This humanitarian cause is noble in its effort to combat truly terrible medical conditions. We are certain your efforts will have a profoundly positive impact on the medical community and overall human health ultimately.”
Acknowledging the gift, FUS Foundation CEO, Neal Kassell, M.D., said, “We are thankful for the generosity of the Caruthers family and for their tradition of supporting social, civic and humanitarian causes. By accelerating the development and availability of treatments with MR-guided focused ultrasound, their gift will save and improve millions of lives worldwide.”
Back to Top |
|
 |
 |
 |
 |
| The Foundation’s patient support organization, Fibroid Relief, conducted its third and most successful free public information event on uterine fibroids on April 27 at the Marriott Marina del Ray in Los Angeles. Over 125 women attended “Fibroid Relief At Last,” an interactive program featuring UCLA clinicians, a naturopathic doctor and well-known patient advocate, Erin S. |
Panelists at the Fibroid Relief at Last event included (from left to right) Dr. Steven Raman of UCLA, Fibroid Relief Patient Advocate Erin S. and Dr. Christopher Tarnay of UCLA.
|
|
Tina Krall, executive director of Fibroid Relief, moderated the panel discussion on April 27.
|
“We received very positive feedback from participants,” says Tina Krall, executive director of Fibroid Relief. “The audience asked a lot of amazing questions and many of them stayed after the program to engage directly with our panelists.”
Krall said one participant was so moved by the information she received that she planned to cancel an upcoming hysterectomy and explore treatment options discussed at the event. |
|
“She had no idea that other treatments were available and might offer better outcomes for her,” Krall explains.
Fibroid Relief At Last events educate women about uterine fibroids and current treatment options, including focused ultrasound. Previous programs were held in 2009 in Chicago and London.
The LA event was also the first to include a discussion of alternative medicine. “Fibroid Relief is a patient-centric organization. We added this topic because of the interest level indicated by questions submitted by patients to our website and Facebook page,” Krall notes. “Questions asked at the event indicate that women are interested in using complimentary and natural therapies in tandem with traditional medical treatments. Adding a naturopathic doctor to the program really rounded out the spectrum of treatment options available today.”
Back to Top |
|
 |
 |
 |
 |
|
To encourage school girls to pursue careers in science and technology, Germany celebrated its tenth annual Girl’s Day on April 21, and one of the newest developments featured was an MR-guided focused ultrasound system, Insightec’s ExAblate 2000.
German Chancellor Angela Merkel learned about MR-guided focused ultrasound during Girl’s Day on April 21. (Photo courtesy of Quelle der Fotos: TK)
Back to Top
|
|
 |
 |
Last Updated on Thursday, May 27 2010 19:50